Table 3 Baseline characteristics of prostate urethral biopsy in patients with NMIBC.
Characteristics | n | Prostatic urethral biopsy | P-value | |
|---|---|---|---|---|
(+) | (−) | |||
Age (years,\(\:\:\stackrel{-}{x}\pm\:s\)) |  | 67.73 ± 10.76 | 68.05 ± 8.83 | 0.808 |
< 65 | 72 | 27 (30.0%) | 45 (33.3%) | 0.705 |
≥ 65 | 153 | 63 (70.0%) | 90 (66.7%) |  |
Tumor size (cm) | Â | Â | Â | 0.041 |
< 3 | 149 | 52 (57.8%) | 97 (71.9%) |  |
≥ 3 | 76 | 38 (42.2%) | 38 (28.1%) |  |
Multiplicity |  |  |  | < 0.001 |
Single | 67 | 11 (12.2%) | 56 (41.5%) | Â |
multiple | 158 | 79 (87.8%) | 79 (58.5%) | Â |
Tumor ___location |  |  |  | < 0.001 |
Trigone/neck | 175 | 76 (84.4%) | 99 (73.3%) | Â |
others | 50 | 14 (15.6%) | 36 (26.7%) | Â |
Stage | Â | Â | Â | 0.001 |
pTa | 26 | 2 ( 2.2%) | 24 (17.8%) | Â |
pT1 | 199 | 88 (97.8%) | 111 (82.2%) | Â |
Grade |  |  |  | < 0.001 |
Low | 43 | 4 ( 4.4%) | 39 (28.9%) | Â |
High | 182 | 86 (95.6%) | 96 (71.1%) | Â |
CIS | Â | Â | Â | 1.000 |
Yes | 49 | 20 (22.2%) | 29 (21.5%) | Â |
No | 176 | 70 (77.8%) | 106 (78.5%) | Â |
recurrent carcinoma |  |  |  | < 0.001 |
Yes | 77 | 46 (51.1%) | 31 (23.0%) | Â |
No | 148 | 44 (48.9%) | 104 (77.0%) | Â |
